A study evaluating efficacy and safety of axitinib in elderly patients with metastatic renal cell carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 16 May 2017
At a glance
- Drugs Axitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- 16 May 2017 New trial record